Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol
; 102(5): 437-441, 2019 May.
Article
in En
| MEDLINE
| ID: mdl-30725494
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Leukemia, Myeloid, Acute
/
Bridged Bicyclo Compounds, Heterocyclic
/
Proto-Oncogene Proteins c-bcl-2
/
Bcl-2-Like Protein 11
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2019
Type:
Article